Literature DB >> 15380140

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.

Roger Hart1, Martha Hickey, Stephen Franks.   

Abstract

Polycystic ovarian morphology is seen on ultrasound in approximately 22% of women. Polycystic ovary syndrome (PCOS) is a common and perplexing endocrine disorder of women in their reproductive years, with a prevalence of up to 10%. Clinical expression of the syndrome varies but commonly includes menstrual cycle disturbance, hyperandrogenism, insulin resistance and obesity. Recently, the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine (ESHRE/ASRM) achieved a new consensus regarding the definition of PCOS. This is now defined as the presence of any two of the following three criteria: (i) polycystic ovaries; (ii) oligo-/anovulation; and/or (iii) clinical or biochemical evidence of hyperandrogenism. This revised definition provides an international framework for the clinical assessment of PCOS and for future research and collaboration.

Entities:  

Mesh:

Year:  2004        PMID: 15380140     DOI: 10.1016/j.bpobgyn.2004.05.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  56 in total

1.  Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

2.  Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.

Authors:  Vasantha Padmanabhan; Natalia R Salvetti; Valentina Matiller; Hugo H Ortega
Journal:  Endocrinology       Date:  2014-07-25       Impact factor: 4.736

3.  Pesticide and insect repellent mixture (permethrin and DEET) induces epigenetic transgenerational inheritance of disease and sperm epimutations.

Authors:  Mohan Manikkam; Rebecca Tracey; Carlos Guerrero-Bosagna; Michael K Skinner
Journal:  Reprod Toxicol       Date:  2012-09-11       Impact factor: 3.143

Review 4.  The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis.

Authors:  Daniel Skubleny; Noah J Switzer; Richdeep S Gill; Mark Dykstra; Xinzhe Shi; Margaret A Sagle; Christopher de Gara; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

5.  Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez; Carol Herkimer; Bachir Abi Salloum; Jacob Moeller; Evan Beckett; Rohit Sreedharan
Journal:  Endocrinology       Date:  2015-04-28       Impact factor: 4.736

6.  Hydrocarbons (jet fuel JP-8) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations.

Authors:  Rebecca Tracey; Mohan Manikkam; Carlos Guerrero-Bosagna; Michael K Skinner
Journal:  Reprod Toxicol       Date:  2013-01-25       Impact factor: 3.143

7.  Core Binding Factor β Expression in Ovarian Granulosa Cells Is Essential for Female Fertility.

Authors:  Somang Lee-Thacker; Yohan Choi; Ichiro Taniuchi; Takeshi Takarada; Yukio Yoneda; CheMyong Ko; Misung Jo
Journal:  Endocrinology       Date:  2018-05-01       Impact factor: 4.736

8.  The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.

Authors:  Selami Demirelli; Husnu Degirmenci; Emrah Ermis; Sinan Inci; Gokay Nar; Mehmet Emin Ayhan; Serdar Fırtına; Hikmet Hamur; Senay Arikan Durmaz
Journal:  Bosn J Basic Med Sci       Date:  2015-10-19       Impact factor: 3.363

9.  Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population.

Authors:  Yan Yang; Jie Qiao; Mei-Zhi Li
Journal:  Reprod Biol Endocrinol       Date:  2010-10-22       Impact factor: 5.211

10.  Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome.

Authors:  Vince Kornél Grolmusz; Orsolya Dóra Acs; Karolina Feldman-Kovács; Ágnes Szappanos; Balázs Stenczer; Tibor Fekete; György Szendei; Péter Reismann; Károly Rácz; Attila Patócs
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.